Thomas Siebel Sells 219,294 Shares of C3.ai (NYSE:AI) Stock

C3.ai, Inc. (NYSE:AI) Chairman Thomas Siebel sold 219,294 shares of the stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $8.67, for a total transaction of $1,901,278.98. Following the completion of the transaction, the chairman owned 722,362 shares of the company’s stock, valued at approximately $6,262,878.54. The trade was a 23.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

C3.ai Price Performance

NYSE:AI opened at $8.47 on Friday. The firm has a market capitalization of $1.19 billion, a P/E ratio of -2.69 and a beta of 2.05. C3.ai, Inc. has a one year low of $7.72 and a one year high of $30.24. The company’s 50-day simple moving average is $10.75 and its 200 day simple moving average is $14.16.

C3.ai (NYSE:AI) last announced its earnings results on Wednesday, February 25th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.11). C3.ai had a negative net margin of 141.35% and a negative return on equity of 55.40%. The business had revenue of $53.26 million for the quarter, compared to the consensus estimate of $75.91 million. During the same period in the prior year, the business posted ($0.12) EPS. C3.ai’s revenue for the quarter was down 46.1% on a year-over-year basis. On average, equities research analysts expect that C3.ai, Inc. will post -2.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On C3.ai

Hedge funds and other institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP lifted its position in C3.ai by 77.1% during the third quarter. Dimensional Fund Advisors LP now owns 1,804,188 shares of the company’s stock valued at $31,284,000 after purchasing an additional 785,508 shares in the last quarter. Two Sigma Investments LP bought a new stake in C3.ai during the third quarter valued at about $13,379,000. Voloridge Investment Management LLC purchased a new stake in C3.ai in the fourth quarter worth about $9,183,000. Federated Hermes Inc. raised its stake in shares of C3.ai by 93,578.8% in the fourth quarter. Federated Hermes Inc. now owns 675,424 shares of the company’s stock worth $9,105,000 after buying an additional 674,703 shares during the period. Finally, Quantbot Technologies LP raised its stake in shares of C3.ai by 2,831.4% in the third quarter. Quantbot Technologies LP now owns 554,472 shares of the company’s stock worth $9,615,000 after buying an additional 535,557 shares during the period. 38.96% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about C3.ai

Here are the key news stories impacting C3.ai this week:

• Positive Sentiment: Unusual call-option activity — Investors bought roughly 108,092 call options on Friday (about a 78% jump vs. typical daily call volume). Heavy call buying can signal bullish, short-term speculation or positioning ahead of potential positive catalysts; it can lift near-term price and implied volatility.
• Positive Sentiment: Strategy tightening may improve conversions — C3.ai is narrowing its AI pilot approach to focus on higher-value deployments aimed at better conversion rates and clearer ROI for enterprise customers, which could improve future revenue visibility and deal economics if execution succeeds. C3.ai Tightens AI Pilot Strategy
• Negative Sentiment: Large insider selling by the chairman — Chairman Thomas Siebel disclosed multi-day sales totaling several hundred thousand shares (transactions on March 17–18 totaling millions of dollars). Large insider reductions, especially by a founder-level figure, are generally viewed negatively by the market and can pressure the stock. Chairman Sells $1.9M in Stock
• Negative Sentiment: Investor litigation probe — Pomerantz LLP has opened an investigation on behalf of C3.ai investors, a development that can increase legal and reputational risk and weigh on sentiment until resolved. Pomerantz Investigation
• Negative Sentiment: Analyst consensus and ratings are weak — Recent analyst coverage shows a consensus “Reduce” rating and continued price-target cuts, reflecting skepticism on near-term revenue and profitability recovery; this contributes to selling pressure. Consensus “Reduce” Rating

Wall Street Analyst Weigh In

Several research firms have commented on AI. KeyCorp dropped their target price on C3.ai from $10.00 to $6.00 and set an “underweight” rating on the stock in a report on Thursday, February 26th. BMO Capital Markets set a $7.00 price target on C3.ai in a report on Thursday, February 26th. JPMorgan Chase & Co. dropped their price target on shares of C3.ai from $10.00 to $7.00 and set an “underweight” rating on the stock in a research note on Thursday, February 26th. UBS Group reissued a “reduce” rating on shares of C3.ai in a research report on Thursday, February 26th. Finally, Citizens Jmp cut shares of C3.ai from an “outperform” rating to a “market perform” rating in a report on Thursday, February 26th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, seven have assigned a Hold rating and six have issued a Sell rating to the company’s stock. According to MarketBeat, C3.ai has a consensus rating of “Reduce” and an average price target of $15.87.

C3.ai Company Profile

C3.ai, Inc is a leading enterprise software provider focused on delivering scalable artificial intelligence (AI) and Internet of Things (IoT) solutions to large organizations. The company’s core offering, the C3 AI Suite, is a comprehensive, model-driven platform that unifies data ingestion, model development, and application deployment. Through its suite of tools, C3.ai enables customers to accelerate digital transformation initiatives by applying advanced machine learning, predictive analytics, and AI-driven insights across a broad range of business functions.

The C3 AI Suite provides a low-code environment for data scientists and application developers to rapidly design, test, and deploy enterprise-scale AI applications.